维普中文期刊产品整合服务
20篇 您的检索式:作者名="Ido L"
    题名 作者 年代 出处 被引量
1Tracking by Affine Kernel Transformations Using Color and Boundary Cues显示文摘Ido L Michael L Ehud R 2009IEEE Trans on Pattern Analysis and Machine Intelligence2009,31,1:1
2Staging of carcinoid tumours with 18 F-DOPA PET: a prospective, diagnostic accuracy study显示文摘Klaas P Koopmans Elisabeth GE de Vries Ido P Kema Philip H Elsinga Oliver C Neels Wim J Sluiter Anouk NA van der Horst-Schrivers Pieter L Jager 2006Lancet Oncology2006,,9:1
3On the relativity of relative measures-accommodating both rank preservation and rank reversals in the AHP显示文摘Ido Millet Thomas L Saaty 2000European Journal of Opearational Research2000,121,:1
4Coordinated design of a PSS and an SVC-based controller to enhance power system stability显示文摘AB IDO M A ABDEL-MAGID Y L 2003Electrical Power and Energy Systems2003,25,9:1
5Association of killer cell immunoglobulin - like receptor polymor- phisms with chronic hepatitis C and responses to therapy in Brazil 显示文摘de Vasconcelos JM de Jesus Mau6s Pereira M6ia L Amaral Ido S 2013Genet Mol Biol2013,36,1:1
6Similarity-based Models of Word Co-occurrence Probabilities显示文摘Ido D Lillian L Fernando C N P 1999Machine Learning1999,34,:1
7Tracking by affine kernel transformations using color and boundary cues显示文摘IDO L MICHAEL L EHUD R 2009IEEE Transactions on Pattern Analysis and Machine Intelligence2009,31,1:1
8Similarity- based Models of Word Co- Occurrence Probabilities显示文摘Ido D Lillian L Femando C N P 1999Machine Learning1999,34,:1
9US, CT, MR and percutaneous biopsy of adre- nalmyeIolipomas显示文摘Gu ido L Stefano C Claud ia dell'A 1995Eur Radiol1995,5,:1
10Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well:results from the MR CLEAN Registry显示文摘Background Randomised controlled trials with perfusion selection have shown benefit of endovascular treatment(EVT)for ischaemic stroke between 6 and 24 hours after symptom onset or time last seen well.However,outcomes after EVT in these late window patients without perfusion imaging are largely unknown.We assessed their characteristics and outcomes in routine clinical practice.Methods The Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry,a prospective,multicentre study in the Netherlands,included patients with an anterior circulation occlusion who underwent EVT between 2014 and 2017.CT perfusion was no standard imaging modality.We used adjusted ordinal logistic regression analysis to compare patients treated within versus beyond 6.5 hours after propensity score matching on age,prestroke modified Rankin Scale(mRS),National Institutes of Health Stroke Scale,Alberta Stroke Programme Early CT Score(ASPECTS),collateral status,location of occlusion and treatment with intravenous thrombolysis.Outcomes included 3-month mRS score,functional independence(defined as mRS 0-2),and death.Results Of 3264 patients who underwent EVT,106(3.2%)were treated beyond 6.5 hours(median 8.5,IQR 6.9-10.6),of whom 93(87.7%)had unknown time of stroke onset.CT perfusion was not performed in 87/106(80.2%)late window patients.Late window patients were younger(mean 67 vs 70 years,p<0.04)and had slightly lower ASPECTS(median 8 vs 9,p<0.01),but better collateral status(collateral score 2-3:68.3%vs 57.7%,p=0.03).No differences were observed in proportions of functional independence(43.3%vs 40.5%,p=0.57)or death(24.0%vs 28.9%,p=0.28).After matching,outcomes remained similar(adjusted common OR for 1 point improvement in mRS 1.04,95%CI 0.56 to 1.93).Conclusions Without the use of CT perfusion selection criteria,EVT in the 6.5-24-hour time window was not associated with poorer outcome in selected patients with favourable clinical and CT/CT angiography characteristics.randomised controlled trials with lenient inclusion criteria are needed to identify more patients who can benefit from EVT in the late window.Luuk Dekker Esmee Venema F Anne V Pirson Charles B L M Majoie Bart J Emmer Ivo G H Jansen Maxim J H L Mulder Robin Lemmens Robert-Jan B Goldhoorn Marieke J H Wermer Jelis Boiten Geert J LycklamaàNijeholt Yvo B W E M Roos Adriaan C G M van Es Hester F Lingsma Diederik W J Dippel Wim H van Zwam Robert J van Oostenbrugge Ido R van den Wijngaard on behalf of the MR CLEAN Registry investigators 2021Stroke & Vascular Neurology2021,6,4:1
11Mean shift trackers with cross-bin metrics显示文摘Ido L 2012IEEE transactions on pattern analysis and machine intelligence2012,34,4:1
12Mean shift tracking with multiple reference color histograms 显示文摘IDO L MICHAEL L EHUD R 2010Computer Vision and Image Under- standing2010,114,4:1
13Similarity-based models of word co-occurrence probabilities显示文摘Ido D Lillian L Fernando C N P 1999Machine Learning1999,34,:1
14The peroxisome proliferator - activated receptor - gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline - deficient, I - amino acid - defined diet 显示文摘UTO H NAKANISHI L IDO A 2005Hepatol Res2005,32,4:1
15Re- versible posterior leu koencephalopa- thy syndrome induced by sunitinib 显示文摘Martin G bell ido L Cruz JJ 2007J Clin Oncol2007,25,23:1
16Tracking by affine kernel transformations using color and boundary cues显示文摘Ido L Michael L Ehud R 2009IEEE Transaction on Pattern Analysis and Machine Intelligence2009,31,1:1
17The peroxisome prolif-erator-activated receptor-gamma agonist,pioglitazone,in-hibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient,l-amino acid-defined diet显示文摘UTO H NAKANISHI L IDO A 0,,04:1
18The peroxisome proliferator-activated receptor-gamma agonist,pioglitazone,inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient,l-amino acid-defined diet显示文摘Uto H Nakanishi L Ido A 2005Hepatol Res2005,32,4:1
19Similarity-based Models of Word Co-occurrence Probabilities 显示文摘Ido D Lillian L Femando C N P 1999Machine Learning1999,,34:1
20Increased sensitivity to Vinca alkaloids in cells overexpressing calmodulin by gene transfection 显示文摘Ido M Lagace L Chafouleas JG 1990Cancer Res1990,50,20:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费